RBC Capital Expects 75% Chance of Sucess for Constellation Pharmaceuticals (CNST) Ph3 MANIFEST-2 Study
Tweet Send to a Friend
RBC Capital analyst Brian Abrahams reiterated an Outperform rating and $50.00 price target on Constellation Pharmaceuticals (NASDAQ: CNST) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
